AQR Capital Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

AQR Capital Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,850	Closed	-$60K	–	2304
2022 Q3	$60K	Buy	2,850 +2,157	+311%	+$58.2K	﹤0.01%	2139
2022 Q2	$17K	Buy	+693	New	+$23.6K	﹤0.01%	2168
2021 Q4	–	Sell	-948	Closed	-$88K	–	2303
2021 Q3	$88K	Hold	948	–	–	﹤0.01%	2207
2021 Q2	$95K	Sell	948 -1,998	-68%	-$195K	﹤0.01%	2190
2021 Q1	$275K	Sell	2,946 -610	-17%	-$61.9K	﹤0.01%	2034
2020 Q4	$293K	Sell	3,556 -362	-9%	-$30.9K	﹤0.01%	1981
2020 Q3	$336K	Buy	3,918 +3,065	+359%	+$357K	﹤0.01%	1877
2020 Q2	$79K	Buy	+853	New	+$47K	﹤0.01%	2068

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AQR Capital Management's VBIV Position: Q4 2022 in Review

AQR Capital Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2022, closing a stake of 2,850 shares — an estimated $60K sold.

AQR Capital Management first reported a position in VBIV in Q2 2020 and held it in 8 quarters. The position peaked at $336K in Q3 2020. 112 funds tracked by Wall St. Rank hold VBIV as of Q4 2022.

AQR Capital Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2022 after selling out during the quarter.
AQR Capital Management sold 2,850 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2022, an estimated $60K.
AQR Capital Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and held it in 8 quarters.
AQR Capital Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $336K in Q3 2020.
112 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2022.

Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.